A medicine helps reduce belly fat in people with HIV and fat loss
Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A medicine called tesamorelin helps people with HIV who have too much belly fat and too little fat elsewhere. It reduces belly fat, improves blood fats, and helps people feel better about their appearance. But if they stop taking it, the benefits go away.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 520 / 58
Evidence Score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A medicine called tesamorelin helps people with HIV who have too much belly fat and too little fat elsewhere. It reduces belly fat, improves blood fats, and helps people feel better about their appearance. But if they stop taking it, the benefits go away.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 520 / 58
Evidence Score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Publication
Related Content
Claims (6)
In a 12-month randomized, double-blind, placebo-controlled trial, continued tesamorelin treatment led to an 18% reduction in visceral adipose tissue, while discontinuation resulted in rapid fat regain, demonstrating a direct and reversible cause-and-effect relationship.
Taking tesamorelin is linked to less belly fat in people with HIV who have body shape changes. This finding is from the abstract summary - full study details were not available
Tesamorelin doesn't significantly change the fat under the skin in people with HIV-related body shape changes. This finding is from the abstract summary - full study details were not available
Tesamorelin helps lower blood fat levels in people with HIV-related body changes. This finding is from the abstract summary - full study details were not available
Taking tesamorelin makes people with HIV feel better about their belly appearance. This finding is from the abstract summary - full study details were not available